Cell is a peer-reviewed scientific journal publishing research papers across a broad range of disciplines within the life sciences. Areas covered include molecular biology, cell biology, systems biology, stem cells, developmental biology, genetics and genomics, proteomics, cancer research, immunology, neuroscience, structural biology, microbiology, virology, physiology, biophysics, and computational biology. The journal was established in 1974 by Benjamin Lewin and is published twice monthly by Cell Press, an imprint of Elsevier. Benjamin Lewin founded Cell in January 1974, under the aegis of MIT Press. He then bought the title and established an independent Cell Press in 1986. In April 1999, Lewin sold Cell Press to Elsevier. The "Article of the Future" feature was the recipient of a 2011 PROSE Award for Excellence in Biological & Life Sciences presented by the Professional and Scholarly Publishing Division of the Association of American Publishers. According to ScienceWatch, the journal was ranked first overall in the category of highest-impact journals (all fields) over 1995–2005 with an average of 161.2 citations per paper. According to the Journal Citation Reports, the journal
Researchers discover strong break on cell division
The protein complex SWI/SNF that loosens tightly wrapped up DNA is also a strong inhibitor of cell division, at the time that cells take on specialized functions. Professor Sander van den Heuvel and PhD researcher Suzan Ruijtenberg ...
Facebook for the proteome
There are approximately 20,000 human genes that encode proteins, but despite remarkable progress since the human genome was first sequenced more than a decade ago, scientists still understand in detail how only a small fraction ...
Researchers uncover key to barley domestication
An international team of researchers including the University of Adelaide have unlocked the genetic key in barley that led to the start of cropping in human agriculture.
Comprehending chemotaxis: Team uncovers the intricate mechanisms that allow certain cells to move
What if cancer cells couldn't move? What if patients – once they're diagnosed with cancer – could take a drug that made cancer cells immobile? The answer is simple: survival rates would skyrocket. But reality is complicated. ...
Key blood pressure drug seen in startling new detail
A new Arizona State University research study has revealed the fine details of how an experimental drug works to regulate blood pressure, paving the way to the development of better drugs.
Study points to unexplored realm of protein biology, drug targets
Scientists at The Scripps Research Institute (TSRI) have devised a powerful set of chemical methods for exploring the biology of proteins.
How RNA machinery navigates our genomic obstacle course
Once upon a time, scientists thought RNA polymerase—the molecule that kicks off protein synthesis by transcribing DNA into RNA—worked like a wind-up toy: Set it down at a start site in our DNA and it would whir steadily ...
Single enzyme's far-reaching influence in human biology and disease
Every cell in the body uses phosphorylation, the process of adding a chemical tag to control a protein's function and fate, such as when it moves from one part of a cell to another or binds to other proteins.
X-ray study may aid in designing better blood pressure drugs
An experiment at the Department of Energy's SLAC National Accelerator Laboratory has revealed in atomic detail how a hypertension drug binds to a cellular receptor that plays a key role in regulating blood pressure. The results ...
Advances in technology and computational analysis paving the way for translational studies
The Human Genome Project gave us an incredible foundation from which to understand our potential genetic repertoire. In order to understand the actual roles of particular genes in disease, however, it is not only critical ...